EA200970720A1 - Средство для лечения рассеянного склероза - Google Patents
Средство для лечения рассеянного склерозаInfo
- Publication number
- EA200970720A1 EA200970720A1 EA200970720A EA200970720A EA200970720A1 EA 200970720 A1 EA200970720 A1 EA 200970720A1 EA 200970720 A EA200970720 A EA 200970720A EA 200970720 A EA200970720 A EA 200970720A EA 200970720 A1 EA200970720 A1 EA 200970720A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- multiple sclerosis
- treatment
- prophylactic
- drug
- pyridazin
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- HEUAVAATAFEENP-UHFFFAOYSA-N 2-benzyl-5-(4-chlorophenyl)-6-(4-methylsulfanylphenyl)pyridazin-3-one Chemical compound C1=CC(SC)=CC=C1C(C(=CC1=O)C=2C=CC(Cl)=CC=2)=NN1CC1=CC=CC=C1 HEUAVAATAFEENP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Предоставлено профилактическое и/или лекарственное средство при рассеянном склерозе, которое имеет высокую эффективность в отношении рассеянного склероза, абсолютно безопасно и может приниматься перорально. Изобретение предоставляет профилактическое и/или лекарственное средство при рассеянном склерозе, содержащее, в качестве активного ингредиента, 2-бензил-5-(4-хлорофенил)-6-[4-(метилтио)фенил]-2Н-пиридазин-3-он или его сольват.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007017328 | 2007-01-29 | ||
| PCT/JP2008/000099 WO2008093495A1 (ja) | 2007-01-29 | 2008-01-28 | 多発性硬化症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200970720A1 true EA200970720A1 (ru) | 2009-12-30 |
Family
ID=39673809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200970720A EA200970720A1 (ru) | 2007-01-29 | 2008-01-28 | Средство для лечения рассеянного склероза |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100075972A1 (ru) |
| EP (1) | EP2127653A1 (ru) |
| JP (1) | JPWO2008093495A1 (ru) |
| KR (1) | KR20090114371A (ru) |
| CN (1) | CN101600435A (ru) |
| AU (1) | AU2008211480A1 (ru) |
| BR (1) | BRPI0805841A2 (ru) |
| CA (1) | CA2669563A1 (ru) |
| EA (1) | EA200970720A1 (ru) |
| MX (1) | MX2009008059A (ru) |
| TW (1) | TW200838535A (ru) |
| WO (1) | WO2008093495A1 (ru) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2307111C (en) | 1997-11-19 | 2009-06-30 | Kowa Co., Ltd. | Novel pyridazine derivatives and drugs containing the same as the active ingredient |
| US20030225081A1 (en) * | 2000-09-18 | 2003-12-04 | Satoshi Nagato | Pyridazinones and triazinones and medicinal use thereof |
-
2008
- 2008-01-28 MX MX2009008059A patent/MX2009008059A/es unknown
- 2008-01-28 BR BRPI0805841-5A patent/BRPI0805841A2/pt not_active IP Right Cessation
- 2008-01-28 EA EA200970720A patent/EA200970720A1/ru unknown
- 2008-01-28 JP JP2008556026A patent/JPWO2008093495A1/ja active Pending
- 2008-01-28 CN CNA2008800032965A patent/CN101600435A/zh active Pending
- 2008-01-28 AU AU2008211480A patent/AU2008211480A1/en not_active Abandoned
- 2008-01-28 WO PCT/JP2008/000099 patent/WO2008093495A1/ja active Application Filing
- 2008-01-28 US US12/516,595 patent/US20100075972A1/en not_active Abandoned
- 2008-01-28 CA CA002669563A patent/CA2669563A1/en not_active Abandoned
- 2008-01-28 EP EP08710303A patent/EP2127653A1/en not_active Withdrawn
- 2008-01-28 KR KR1020097015733A patent/KR20090114371A/ko not_active Application Discontinuation
- 2008-01-28 TW TW097103099A patent/TW200838535A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2669563A1 (en) | 2008-08-07 |
| MX2009008059A (es) | 2009-08-12 |
| AU2008211480A1 (en) | 2008-08-07 |
| JPWO2008093495A1 (ja) | 2010-05-20 |
| EP2127653A1 (en) | 2009-12-02 |
| US20100075972A1 (en) | 2010-03-25 |
| TW200838535A (en) | 2008-10-01 |
| CN101600435A (zh) | 2009-12-09 |
| KR20090114371A (ko) | 2009-11-03 |
| WO2008093495A1 (ja) | 2008-08-07 |
| BRPI0805841A2 (pt) | 2011-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063958L (no) | HIV integrase inhibitorer | |
| UA108087C2 (ru) | Твердые формы n-(4-(7-азабицикло[2.2.1]гептан-7-ил)-2-(трифторметил)фенил)-4-оксо-5-(трифторметил)-1,4-дигидрохинолин-3-карбоксамида | |
| CY1116509T1 (el) | Θεραπευτικος συνδυασμος που περιλαμβανει ντολουτεγκραβιρη, αβακαβιρη και λαμιβουδινη | |
| MX2009006535A (es) | Derivados de indol-4-il-pirimidinil-2-il-amina y su uso como inhibidores de cinasa dependiente de ciclina. | |
| ATE447559T1 (de) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen | |
| WO2005089738A3 (en) | Use and administration of bacterial efflux pump inhibitors | |
| NO20072443L (no) | Fungicide aktive ingredienskombinasjoner | |
| EA201390609A1 (ru) | ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ | |
| NO20073105L (no) | Pyridazinonforbindelser | |
| NO20092569L (no) | Inhibitorer av Akt-aktivitet | |
| TN2009000446A1 (en) | P70 s6 kinase inhibitors | |
| NO20084749L (no) | Organiske forbindelser og deres anvendelser | |
| WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
| DK3292867T3 (da) | Ny brug af triazol(4,5-d)pyrimidinderivater til brug i forebyggelsen og behandlingen af bakteriel infektion | |
| EA201170828A1 (ru) | Конденсированные гетероциклические производные оксадиазола, подходящие для лечения рассеянного склероза | |
| DK1610787T3 (da) | Synergistisk kombination der omfatter roflumilast og et antikolinergt middel der er valgt blandt tiotropiumsalte til behandling af respiratoriske sygdomme | |
| IL280755A (en) | Compounds 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol and their therapeutic use | |
| WO2004099165A3 (en) | Heterocyclic compounds and hydro isomers thereof | |
| EA201891240A1 (ru) | 1,3,4-тиадиазольные соединения и их применение в лечении рака | |
| PH12020550673A1 (en) | Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv) | |
| EA201792558A1 (ru) | Противогрибковый 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-триазол-1-ил)метил)-5-(2,4-дифторфенил)тетрагидрофуран-3-ил)метокси)-3-метилфенил)пиперазин-1-ил)-n-(2-гидроксициклогексил)бензамид или его фармацевтически приемлемая соль | |
| EA200970720A1 (ru) | Средство для лечения рассеянного склероза | |
| DK2089030T3 (da) | Middel til profylakse eller behandling af alkoholafhængighed eller lægemiddelafhængighed | |
| HK1087638A1 (en) | Use of tyrosine kinase inhibitors to treat diabetes | |
| WO2012102560A3 (ko) | 신규한 4-ｏ-메틸호노키올 유도체 및 이를 유효성분으로 포함하는 염증질환 치료용 조성물 |